Because of the COVID-19 pandemic, the patient was only seen in the outpatient clinic in March 2022 when glycemic control was at target (FPG 4.89 mmol/L
Semaglutide Semaglutide is one of the most popular GLP-1 drugs, and its predominant brand name, Ozempic, has become synonymous with the drug class
If approved, it would be the first and only once-weekly insulin option available in the United States
A true plateau is when weight stays about the same for an extended period, even though treatment and habits have not changed
Both programs let you compare prices, and sometimes, one might offer a better discount than the other, depending on your location and pharmacy
New class of medication: GIP/GLP-1 agonist: Mounjaro Mounjaro (Tirzepatide) is a new weekly injection for the treatment of type 2 diabetes